Imunon, Inc.
IMNN
$0.849
$0.01181.41%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -3.29M | -1.62M | -2.93M | -2.62M | -2.62M |
| Gross Profit | 3.29M | 1.62M | 2.93M | 2.62M | 2.62M |
| SG&A Expenses | 7.49M | 7.99M | 8.25M | 8.40M | 9.74M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 19.13M | 20.95M | 19.90M | 20.36M | 21.03M |
| Operating Income | -19.13M | -20.95M | -19.90M | -20.36M | -21.03M |
| Income Before Tax | -18.62M | -20.73M | -19.36M | -20.13M | -20.80M |
| Income Tax Expenses | -- | -1.28M | -1.28M | -1.28M | -1.28M |
| Earnings from Continuing Operations | -18.62 | -19.45 | -18.08 | -18.85 | -19.52 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -18.62M | -19.45M | -18.08M | -18.85M | -19.52M |
| EBIT | -19.13M | -20.95M | -19.90M | -20.36M | -21.03M |
| EBITDA | -18.89M | -20.68M | -19.62M | -20.09M | -20.78M |
| EPS Basic | -1.65 | -1.89 | -1.92 | -2.02 | -2.17 |
| Normalized Basic EPS | -1.03 | -1.27 | -1.29 | -1.33 | -1.42 |
| EPS Diluted | -1.65 | -1.89 | -1.92 | -2.02 | -2.17 |
| Normalized Diluted EPS | -1.03 | -1.27 | -1.29 | -1.33 | -1.42 |
| Average Basic Shares Outstanding | 47.77M | 42.65M | 37.58M | 37.32M | 36.20M |
| Average Diluted Shares Outstanding | 47.77M | 42.65M | 37.58M | 37.32M | 36.20M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |